CN220255709U

CN220255709U - Nicotine salt powder inhaler system and inhaler product

Info

Publication number: CN220255709U
Application number: CN202321704797.4U
Authority: CN
Inventors: 刘炎子; 容辉; 尹聪聪
Original assignee: Shenzhen Huabao Collaborative Innovation Technology Research Institute Co ltd
Current assignee: Shenzhen Huabao Collaborative Innovation Technology Research Institute Co ltd
Priority date: 2023-06-30
Filing date: 2023-06-30
Publication date: 2023-12-29
Anticipated expiration: 2033-06-30

Abstract

The utility model discloses a nicotine salt powder inhaler system and an inhaler product, wherein the inhaler system comprises a holder, and further comprises an inhaler product, and the inhaler product can be inserted into the holder; the inhaler product is provided with a capsule containing nicotine salt powder and the holder is provided with a puncturing device which punctures the inhaler product and the capsule in the inhaler product when the inhaler product is inserted into the holder, so that the nicotine powder is released upon inhalation. The nicotine salt powder inhaler system of the present utility model allows the inhaler product provided with the capsule releasing nicotine salt powder to be directly discarded after the user has finished using the inhaler. In the using process, the disposable inhaler product is adopted, nicotine salt powder released by the capsule cannot contact with the retainer, a user does not need to frequently clean the retainer, and the using experience of the user is improved under the condition of ensuring sanitation and safety.

Description

Nicotine salt powder inhaler system and inhaler product

Technical Field

The utility model relates to the technical field of inhalers, in particular to a nicotine salt powder inhaler system and an inhaler product.

Background

Conventional nicotine salt powder inhalation devices typically load nicotine salt powder into the device body or place it into the device body through a capsule. When the former is used, a user can directly suck nicotine salt powder in the device body; the latter can be used after puncturing the capsule. Regardless of the device, a part of nicotine salt powder remains in the device body during the use process, so that the device body loaded with nicotine salt powder needs to be cleaned after each use, and the traditional nicotine salt powder inhalation device is troublesome to clean in order to ensure the sanitation and safety during each use.

Disclosure of Invention

The technical problem underlying the present utility model is to provide a nicotine salt powder inhaler system and an inhaler product, which address the drawbacks of the prior art.

The technical scheme adopted for solving the technical problems is as follows:

there is provided a nicotine salt powder inhaler system comprising a holder, an inhaler product, the inhaler product being partially insertable into the holder and freely pluggable.

The inhaler product comprises a tubular body in which a capsule loaded with nicotine salt powder is arranged, the capsule being movable in the axial and radial directions of the tubular body, the ratio of the inner diameter of the tubular body to the radial diameter of the capsule being in the range of 1.50-2.21, the ratio of the displaceable distance of the capsule in the axial direction of the tubular body to the longitudinal length of the capsule being in the range of 1.25-1.56.

The holder is provided with piercing means which pierce the tubular body and the capsule therein when the inhaler product is inserted into the holder, so that air sequentially enters the holder and the tubular body of the inhaler product, so that nicotine powder is released from the capsule upon inhalation.

Preferably, the holder comprises a holder body, a containing cavity is arranged in the holder body, a first air passage is arranged at the upstream of the containing cavity, the first air passage is communicated with the outside air, an opening is arranged at the downstream of the containing cavity, and the inhaler product can be inserted into the containing cavity through the opening.

Preferably, the lancing device comprises a lancing member, the sidewall of the receiving chamber being provided with perforations through which the lancing member can pass.

Preferably, the lancing device further comprises an elastic member, and the elastic member is used for resetting after the lancing member moves.

Preferably, the lancing device further comprises a cap, the lancing member and the resilient member being disposed between the cap and the holder body.

Preferably, the inhaler product further comprises first and second end members located within the interior cavity of the tubular body, the first and second end members defining a capsule cavity within the interior cavity, the capsule cavity being loaded with the capsule.

Preferably, the first end piece is provided with a through second air passage, and the diameter of the second air passage is smaller than the outer diameter of the capsule.

The second end piece is provided with a third through air passage, and the diameter of the third air passage is smaller than the outer diameter of the capsule but larger than or equal to the diameter of the second air passage.

Preferably, the inhaler product further comprises a first limiting plug body and a second limiting plug body, wherein the first limiting plug body is sealed at the upstream of the inner cavity of the tubular body and is detachable, and the second limiting plug body is sealed at the downstream of the inner cavity of the tubular body and is detachable.

The present utility model also provides an inhaler product comprising a tubular body made of vegetable fibres or hydroxypropyl cellulose and a capsule disposed inside the tubular body for use with a nicotine salt powder inhaler system as described above.

The implementation of the utility model has the following beneficial effects:

the capsule loaded with nicotine salt powder is arranged in the inhaler product, and when the user uses it, the inhaler product is directly inserted into the holder, and the inhaler product and the capsule in the inhaler product are pierced by the piercing means on the holder. When the user draws, the capsule releases the pre-loaded nicotine salt powder through the pierced area. After the user has sucked up the use, the inhaler product provided with the capsule releasing the nicotine salt powder can be discarded directly. In the using process, the disposable inhaler product is adopted, nicotine salt powder released by the capsule cannot contact with the retainer, a user does not need to frequently clean the retainer, and the using experience of the user is improved under the condition of ensuring sanitation and safety.

Drawings

The foregoing and other objects, features and advantages of the utility model will be apparent from the following more particular descriptions of exemplary embodiments of the utility model as illustrated in the accompanying drawings wherein like reference numbers generally represent like parts throughout the exemplary embodiments of the utility model.

FIG. 1 is a schematic perspective view of a nicotine salt powder inhaler system in an embodiment of the present utility model;

FIG. 2 is a schematic view of a partial explosion of FIG. 1;

FIG. 3 is an exploded view of FIG. 1;

FIG. 4 is a cross-sectional view of FIG. 3;

FIG. 5 is a sectional view of a nicotine salt powder inhaler system in an embodiment of the present utility model in use;

FIG. 6 is a cross-sectional view of the holder body and lancing device of the present utility model;

FIG. 7 is a cross-sectional view of the retainer body of the present utility model;

fig. 8 is a cross-sectional view of an inhaler article of the present utility model.

Detailed Description

Embodiments of the present utility model will be described in more detail below with reference to the accompanying drawings. While embodiments of the present utility model are illustrated in the drawings, it should be understood that the present utility model may be embodied in various forms and should not be limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the utility model to those skilled in the art.

As shown in fig. 1-5, the present utility model discloses a nicotine salt powder inhaler system comprising a holder 20, further comprising an inhaler product 10, the inhaler product 10 being freely insertable into the holder 20, and the inhaler product 10 being partly insertable into the holder 20; the inhaler product 10 is provided with a capsule 11 containing nicotine salt powder, the holder 20 is provided with a puncturing device 30, and when the inhaler product 10 is inserted into the holder 20, the puncturing device 30 punctures the tubular body 12 of the inhaler product 10 and the side wall of the capsule 11 in the tubular body 12, so that upon inhalation the nicotine powder is released from the punctured capsule hole.

The capsule 11 loaded with nicotine salt powder is arranged in the tubular body 12 of the inhaler product 10, and when the user is using, the inhaler product 10 is directly inserted into the holder 20, the tubular body 12 of the inhaler product 10 and the capsule 11 in the tubular body 12 are pierced by the piercing means 30 on the holder 20. When the user draws, the capsule 11 releases the pre-loaded nicotine salt powder through the pierced hole area. After the user has sucked up the inhaler product 10 provided with the capsule 11 releasing nicotine salt powder can be discarded directly. In the using process, the disposable inhaler product 10 is adopted, nicotine salt powder released by the capsule 11 can not contact with the retainer 20, a user does not need to frequently clean the retainer 20, and the using experience of the user is improved under the condition of ensuring sanitation and safety.

As shown in fig. 6 to 7, the retainer 20 includes a retainer body 21, a housing chamber 211 is provided in the retainer body 21, a first air passage 212 is provided upstream of the housing chamber 211, and the first air passage 212 communicates with the outside air; the holder 20 further comprises a base 22, the base 22 is matched with the holder body 21 and is arranged at the bottom of the holder body 21, a cavity is formed after the base 22 and the holder body 21 are assembled, an air guide hole 221 is formed in the base 22, the air guide hole 221 is communicated with the cavity, so that external air can enter the cavity, and then the air enters the accommodating cavity 211 through the first air passage 212, so that the entering air can enter the inhaler product 10; the receiving cavity 211 is dimensioned to match the inhaler product 10, and an opening 2111 is provided downstream of the receiving cavity 211, the inhaler product 10 being insertable into the receiving cavity 211 through the opening 2111; the provision of the receiving cavity 211 serves on the one hand to hold the inhaler product 10 stationary and on the other hand to enable positioning mounting and dismounting of the inhaler product 10 with respect to the holder 20 with less effort.

It will be appreciated that when the inhaler article 10 is inserted into the receiving cavity 211, the first air passage 212 communicates with the interior cavity 17 of the tubular body 12 of the inhaler article 10, such that ambient air may enter the tubular body 12 of the inhaler article 10 via the first air passage 212, ensuring that the user may draw normally.

In some specific embodiments, as shown in fig. 2-6, lancing device 30 includes lancing member 31, the sidewall of receiving chamber 211 is provided with perforations 2112, and lancing member 31 can pass through perforations 2112; the piercing member 31 may be made of a rigid material having sufficient rigidity to pierce, pierce or activate the capsule 11 within the capsule cavity 171 of the tubular body 12 of the inhaler product 10, preferably the piercing member 31 is made of a metallic material; further, the piercing end of the piercing member 31 is preferably of a sharp design, such as a steel needle, to facilitate piercing, activating the capsule 11 within the tubular body 12; it will be appreciated that the piercing member 31 is configured to extend into the housing along a longitudinal axis perpendicular to the side walls of the receiving cavity 211 and pierce the capsule 11, the vertical piercing manner of the present utility model reduces the chance of powder falling into the receiving cavity 211, and without touching the inhaler product 10 by hand, the piercing of the capsule 11 can be achieved by operating the piercing means 30, which is more convenient to operate, and avoids deformation or breakage of the inhaler product 10 due to touching, as compared to the prior bottom-up piercing manner.

In a specific embodiment, the puncturing device 30 comprises at least two puncturing elements 31 arranged in parallel and spaced apart, it being understood that the puncturing elements 31 may be arranged in two, three, four or more, with the arrangement of a plurality of puncturing elements 31 being without limitation, for accelerating the release of the nicotine salt powder in the capsule 11; two piercing elements 31 are arranged in parallel and spaced apart relationship, the piercing elements 31 being perpendicular to the axial direction of the inhaler product 10, the distance between the two piercing elements 31 being between 10mm and 15 mm; since the nicotine salt powder is sunk under the influence of gravity, wherein at least one piercing member 31 is arranged corresponding to the round bottom arc surface of the capsule 11, when an air flow exists in the inhaler product 10, the air flow generates a cutting stress for rotating the capsule 11 through the arc bottom surface, and the centrifugal air flow can drive the capsule 11 after the damaged capsule shell to do centrifugal rotation motion in the inhaler product 10 so as to throw the nicotine salt powder out of the capsule shell, and under the action of the suction air flow, the nicotine salt powder particles are sucked into the body along the extending direction of the inhaler product 10.

In a specific embodiment, as shown in fig. 2-6, lancing device 30 further includes an elastic member 32, wherein elastic member 32 is configured to return after lancing member 31 is moved; the elastic member 32 may be a compression spring, the elastic member 32 may be sleeved on the piercing member 31, the elastic member 32 may be coaxially disposed with the piercing member 31, when the elastic member 32 is in a normal state, the extending length of the piercing member 31 exceeds the elastic member 32, the other end of the elastic member 32 may abut against the side wall of the accommodating cavity, when the piercing member 31 extends into the housing along the longitudinal axis perpendicular to the side wall of the accommodating cavity 211 and pierces the capsule 11, the elastic member 32 is compressed, and when the piercing member 31 completes piercing, the elastic member 32 gives the elastic force to the piercing member 31 to enable the piercing member 31 to move backwards and reset, so as not to affect the release of the nicotine salt powder from the capsule 11.

As shown in fig. 2-6, lancing device 30 further includes a push cap 33, lancing member 31 and resilient member 32 being disposed between push cap 33 and holder body 21. The retainer body 21 is provided with a pressing groove 213 recessed corresponding to the position of the pressing cap 33, the pressing cap 33 is provided in the pressing groove 213 and movable relative to the pressing groove 213, and the puncture member 31 is provided in the pressing cap 33 and held between the pressing cap 33 and the retainer body 21; that is, the piercing device 30 of the present utility model can be configured to destroy the capsule 11 when being pressed, the user can press the pressing cap 33 according to the grasping habit, and then drive the piercing member 31 to achieve the piercing purpose, the operation is simple and convenient, and the piercing member 31 can be reset in time. In use, pressing the pressing cap 33 drives the puncturing element 31 to move towards a position close to the capsule 11, puncturing the capsule shell of the capsule 11 through the perforation 2112, compressing the elastic element 32, abutting the end wall of the pressing cap 33 against the inner wall surface of the pressing groove 213 of the retainer body 21, releasing the pressing cap 33, resetting under the elastic force of the elastic element 32, moving the puncturing element 31 towards a position far away from the capsule cavity, when the inhaler product 10 has airflow flowing therein, the airflow can drive the capsule 11 after the capsule 11 shell is damaged to perform centrifugal rotation movement in the inhaler product 10 so as to throw the nicotine salt powder out of the capsule shell, and the nicotine salt powder particles are sucked by a user along the extending direction of the inhaler product 10 under the action of the inhalation airflow.

In the embodiments of the present application, the inhaler article 10 comprises a tubular body 12 of vegetable fibers or hydroxypropyl cellulose, the tubular body 12 being generally circular in shape with an outer diameter of no more than 7.1mm + -15% and a length of between 30mm and 50 mm. The tubular body 12 may have an inner lumen 17 extending along a longitudinal axis. The tubular body 12 preferably has a uniform thickness along its length for ease of manufacture. Further, the tubular body 12 preferably has a thickness of 0.2mm-1mm, within which the puncturing device 30 may more conveniently puncture the capsule 11.

As shown in fig. 4, 5 and 8, a capsule cavity 171 penetrating along the axial direction is arranged in the tubular body 12, the capsule 11 is arranged and held in the capsule cavity 171, the nicotine salt powder in the capsule 11 is shaped by lactose or mannitol, and the shaping mode can be a powder mixing mode or a spray drying mode; in use, the capsule cavity 171 is kept in air circulation from bottom to top, a user can suck from the downstream of the capsule cavity 171, external air can enter from the upstream of the capsule cavity 171, centrifugal air flow can be formed in the capsule cavity 171 to drive the pierced capsule 11 to rotate, nicotine salt powder loaded in the capsule 11 is thrown out, and the nicotine salt powder is sucked into a body from the downstream of the inhaler product 10 along the extending direction of the capsule cavity 171 under the action of suction force.

As shown in fig. 4-5, the inhaler product 10 further comprises a first end member 13 and a second end member 14, the first end member 13 being located upstream of the interior cavity 17 of the tubular body 12, the second end member 14 being located downstream of the interior cavity 17 of the tubular body 12, the first end member 13 and the second end member 14 defining a capsule cavity 171 within the interior cavity 17, the capsule 11 being disposed within the capsule cavity 171, the capsule cavity 171 being defined so that the capsule 11 can be held within the capsule cavity 171, the capsule cavity 171 being defined as a cylindrical space configured to receive the capsule 11. The capsule cavity 171 may define a space configured to receive the capsule 11 having an oval or rounded rectangular shape. The capsule cavity 171 may have a substantially uniform or consistent diameter along the length of the capsule cavity 171. The capsule cavity 171 may have a circular transverse cross-section along the length of the capsule cavity 171. The capsule cavity 171 may have a cylindrical shape. The configuration of capsule cavity 171 relative to capsule 11 may allow for stable rotation of capsule 11 within capsule cavity 171. The capsule 171 extends axially upstream and downstream along the tubular body 12, from which the user can inhale downstream of the capsule 171, and from which ambient air can enter upstream of the capsule 171, during which the capsule 11 can rotate steadily about the axial axis of the tubular body 12.

In a specific embodiment, the size and appearance of the capsule may be selected with reference to the chinese medical packaging association group standard "hollow capsule size and appearance quality". Taking capsule No. 3 as an example, the length dimension of the capsule is 16mm and the diameter is 5.5mm.

The first end member 13 may be a hollow cylindrical structure, and a second air passage 131 penetrating along the axial direction of the tubular body 12 is provided on the first end member 13, and the air inlet end of the tubular body 12 is disposed upstream of the second air passage 131, that is, the external air enters from the upstream of the second air passage 131 and flows to the capsule 171 through the downstream of the second air passage 131. In order to allow a stable release of nicotine salt from the capsule 11, the capsule is movable over a limited distance in the axial and radial direction of the tubular body, the inner diameter of the capsule cavity 171, i.e. the ratio of the inner diameter of the tubular body to the radial diameter of the capsule, is in the range of 1.50-2.21, and the ratio of the displaceable distance of the capsule in the axial direction of the tubular body to the longitudinal length of the capsule is in the range of 1.25-1.56. In this application, the displaceable distance refers to the distance that moves axially within the capsule cavity.

In a specific embodiment, the first end piece 13 may be an annular fragrance-carrying substrate, the inner diameter of which is equal to the outer diameter of the second air passage 131, and the outer diameter of which is equal to the inner diameter of the tubular body 12; the height of the annular fragrance-carrying substrate is equal to the extension length of the second air duct 131. The annular fragrance-carrying substrate can be a porous material, such as polyethylene, aerogel material, or the like.

The second end member 14 is provided with a third air passage 141 penetrating along the axial direction upstream and downstream of the tubular body 12, in particular, the second end member 14 may be a screen layer with a screen mesh therein, and the arrangement of the second end member 14 forms a partition member of the capsule cavity 171 on the one hand, that is, cooperates with the first end member 13 to define the capsule cavity 171; on the other hand, the arrangement of the second end piece 14 has a filtering effect, which dissociates the shaped nicotine salt powder from lactose or mannitol, causing lactose or mannitol to be deposited in the mouth, and the nicotine salt powder to be able to enter the lungs. The downstream of the second end member 14 and the tubular body 12 defines an air channel 172 in the inner cavity 17, the downstream of the tubular body 12 can also be understood as a suction nozzle end, so that the suction is convenient for a user, the air channel 172 is communicated with the third air channel 141 up and down, the arrangement of the air channel 172 provides a certain structural strength for the tubular body 12 on one hand, and on the other hand, an annular fragrance-carrying substrate like the first end member 13 can be sleeved on the periphery of the air channel 172; on the other hand, unlike conventional inhaler systems, the filter screen layer of the present utility model is provided in the inhaler product 10, and the powder hardly falls into the holder 20 during the suction process, and the inhaler product 10 is directly discarded after the use, without the need for disassembly and cleaning of the filter screen layer, and the use is more convenient.

In some specific embodiments, the second end member 14 may be made of a metal material, a polymer material, or an antistatic material. The cross-sectional shape of the third air passage 141 may be square, diamond, triangle, circle, etc.; the number of the third air passages 141 is preferably at least 4 or more, and is not particularly limited.

In some specific embodiments, as shown in fig. 2-3, the inhaler product 10 further comprises a first stopper body 15 and a second stopper body 16, the first stopper body 15 being sealed and removable upstream of the interior cavity 17 of the tubular body 12, the second stopper body 16 being sealed and removable downstream of the interior cavity 17 of the tubular body 12; the first limit plug body 15 and the second limit plug body 16 can be sealing plugs; it will be appreciated that the first stopper body 15 and the second stopper body 16 are used to seal the inhaler product 10 upstream and downstream, respectively, to ensure that the interior of the inhaler product 10 is sealed prior to use; before use, the first stopper body 15 and the second stopper body 16 at both ends of the inhaler product 10 are removed, and then the inhaler product 10 is mounted in the holder 20. The first limiting plug body 15 comprises a plug cap portion and a plug stem portion which are integrally formed, and the plug stem portion is in interference fit with the second air passage 131.

In a specific embodiment, an impermeable barrier layer is applied to the inner wall of the tubular body 12 of the inhaler article 10, the barrier layer being configured to prevent permeation of oxygen, nitrogen, nicotine and other substances, and the barrier layer being made of aluminum foil, a copolymer of acrylonitrile and methyl acrylate, or a combination of both.

The present utility model also provides an inhaler product 10, as shown in fig. 8, the inhaler product 10 comprising a tubular body 12 and a capsule 11, the capsule 11 being arranged inside the tubular body 12 for use with the nicotine salt powder inhaler system described above. The capsule 11 loaded with the nicotine salt powder is arranged in the inhaler product 10, so that the nicotine salt powder inhaler system is convenient to install and insert when in use, the inhaler product 10 is a disposable consumable product, and the user experience is improved without repeated cleaning after the use.

The implementation of the utility model has the following beneficial effects:

the capsule 11 loaded with nicotine salt powder is arranged in the tubular body 12 of the inhaler product 10, and when the user is using, the inhaler product 10 is directly inserted into the holder 20, and the tubular body 12 and the capsule 11 in the tubular body 12 are pierced by the piercing means 30 on the holder 20. When the user draws, the capsule 11 releases the pre-loaded nicotine salt powder through the pierced area. After the user has sucked up the inhaler product 10 provided with the capsule 11 releasing nicotine salt powder can be discarded directly. In the using process, the disposable inhaler product 10 is adopted, nicotine salt powder released by the capsule 11 can not contact with the retainer 20, a user does not need to frequently clean the retainer 20, and the using experience of the user is improved under the condition of ensuring sanitation and safety.

The foregoing description of embodiments of the utility model has been presented for purposes of illustration and description, and is not intended to be exhaustive or limited to the embodiments disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the various embodiments described. The terminology used herein was chosen in order to best explain the principles of the embodiments, the practical application, or the improvement of technology in the marketplace, or to enable others of ordinary skill in the art to understand the embodiments disclosed herein.

Claims

1. A nicotine salt powder inhaler system comprising a holder, an inhaler product, said inhaler product being partially insertable into said holder and freely pluggable, characterized in that:

the inhaler product comprises a tubular body in which a capsule loaded with nicotine salt powder is arranged, the capsule being movable in the axial and radial directions of the tubular body, the ratio of the inner diameter of the tubular body to the radial diameter of the capsule being in the range of 1.50-2.21, the ratio of the displaceable distance of the capsule in the axial direction of the tubular body to the longitudinal length of the capsule being in the range of 1.25-1.56, a puncturing device being arranged on the holder, the puncturing device being arranged to puncture the tubular body and the capsule in the tubular body after insertion of the inhaler product into the holder, so that air enters the holder and the tubular body of the inhaler product in sequence, such that upon suction the nicotine powder is released from the capsule.

2. A nicotine salt powder inhaler system as claimed in claim 1, wherein the holder comprises a holder body, a receiving chamber being provided in the holder body, a first air passage being provided upstream of the receiving chamber, the first air passage being in communication with ambient air, an opening being provided downstream of the receiving chamber, the inhaler product being insertable into the receiving chamber through the opening.

3. A nicotine salt powder inhaler system as claimed in claim 2, wherein the puncturing means comprises a puncturing member, the side wall of the receiving chamber being provided with perforations through which the puncturing member can pass.

4. A nicotine salt powder inhaler system according to claim 3, wherein the puncturing device further comprises a resilient member for return after movement of the puncturing member.

5. The nicotine salt powder inhaler system of claim 4, wherein the lancing device further comprises a cap, the lancing member and resilient member being disposed between the cap and the holder body.

6. The nicotine salt powder inhaler system of claim 1, further comprising first and second end pieces positioned within the interior cavity of the tubular body, the first and second end pieces defining a capsule cavity within the interior cavity, the capsule cavity being loaded with the capsule.

7. The nicotine salt powder inhaler system of claim 6, wherein the first end piece is provided with a second air passage therethrough, the second air passage having a diameter that is less than the outer diameter of the capsule;

8. The nicotine salt powder inhaler system of claim 7, further comprising a first stopper body sealed upstream of the lumen of the tubular body and removable, and a second stopper body sealed downstream of the lumen of the tubular body and removable.

9. An inhaler product comprising a tubular body made of vegetable fibres or hydroxypropylcellulose and a capsule disposed inside the tubular body for use with a nicotine salt powder inhaler system according to any of claims 1-8.